瑞银集团增持恒瑞医药(01276)20.44万股 每股作价约85.88港元

Group 1 - UBS Group increased its stake in Heng Rui Medicine (01276) by 204,400 shares at a price of approximately 85.88 HKD per share, totaling around 17.55 million HKD [1] - After the increase, UBS's total shareholding in Heng Rui Medicine reached approximately 18.18 million shares, representing a holding percentage of 7.04% [1]